Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19 products and a number of its cancer drugs.
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
More than 90% of U.S. population can ditch facemasks under CDC Covid guidance : Rashtra News #population #ditch #facemasks #CDC #Covid #guidance US President Joe Biden holds up a KN95 mask as he delivers an update on his Administrations whole-of-government COVID-19 surge response at the White House in Washington, DC, on January 13, 2022.Jim Watson